Indiana residents and federal officials are urging state health regulators to stop two rival hospitals in Terre Haute from ...
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
The Centers for Medicare & Medicaid Services Nov. 26 proposed changes to increase oversight of the Medicare Advantage and ...
Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...
The Biden administration is attempting to push through a slew of reforms to the controversial MA program in its final months ...
The proposed rule could give millions of Americans access to the new drugs; it will also put pressure on the incoming Trump administration.
The nomination of Dr. Mehmet Oz to head the Centers for Medicare and Medicaid Services (CMS) has stirred debates about the future of federal health programs under the incoming Trump administration.
Washington — Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare and Medicaid under a new rule the Biden ...
More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the ...
The Biden administration Tuesday announced plans to provide coverage for a class of costly anti-obesity medications including Wegovy and Zepbound for those enrolled in Medicare and Medicaid.